Incyte’s Acquisition of Villaris Therapeutics

Sidley represented Incyte on the deal.Incyte (NASDAQ:INCY) announced its agreement to acquire Villaris Therapeutics, a biopharmaceutical company focused on the development of novel antibody therapeutics. The company’s…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Martina Bellini

Author: Martina Bellini

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here